Search results for: OHE Consulting
Filter search results
The Impact of New Medicines in the NHS: 70 Years of Innovation
1 August 2018
In 2018, the NHS turns 70. This OHE Consulting Report demonstrates the contribution and impact of medicines to the health economy in the UK throughout the history of the NHS….
Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
1 August 2018
This OHE Consulting Report reviews “Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS.” The project was funded by the ABPI. For the year 2015/16, the Treasury reported…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
In this report commissioned by the ABPI in Wales, OHE Consulting examines the use of medicines in primary care in Wales since 2000 compared to the other countries of the…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
A new OHE Consulting Report examines whether respondents completing abstract, hypothetical priority-setting exercises in stated preference studies agree with the policy implications of their choices. Stated preference studies are increasingly…
Minimal Access Surgery – Why Don’t We Do More?
20 March 2018
OHE Consulting publishes a report on the barriers to the uptake of minimal access surgery in the NHS and private sector. Surgical practice has come a long way, barely recognisable…
Appraising Ultra-Orphan Drugs: Is Cost-per-QALY Appropriate?
22 March 2018
A new OHE report discusses NICE’s introduction of a cost-effectiveness threshold to appraise ultra-orphan drugs. A new OHE Consulting Report has been published that discusses the use of a cost-per-QALY…
Unrelieved Pain in Palliative Care in England
2 September 2019
…G., Garau, M., 2019. Unrelieved Pain in Palliative Care in England. OHE Consulting Report. London: Office of Health Economics. Available at: https://www.ohe.org/publications/unrelieved-pain-palliative-care-england Sampson, C.J., 2016. Identifying Objects of Value at…
Ethical and Economic Issues in the Appraisal of Medicines for Ultra-rare (or Ultra-orphan) Conditions
13 January 2020
In light of concerns that not all medicines for ultra-rare (also known as ultra-orphan) conditions are appraised under the same NICE process, a new OHE Consulting Report discusses the distinct…
Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA
28 February 2019
…and Cures: A Discrete Choice Experiment. OHE Consulting Report, London: Office of Health Economics. RePEc. Marsden, G. and Towse, A., 2017. Exploring the Assessment and Appraisal of Regenerative Medicines and Cell…